Oppenheimer downgraded price targets on Citigroup, Bank of America, Morgan Stanley, and Goldman Sachs, citing stretched valuations after strong runs. They still view Morgan Stanley and Goldman as best-in-breed, expecting strong trading revenues and M&A activity.
The downgrades come before earnings season, which could prove right or wrong. Oppenheimer also highlighted underperformers in private equity (KKR, Blackstone, ARES), down 20-35% in 2026, suggesting a recalibration toward undervalued financial stocks.